TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive NCI Drug Development Program Produced 7 Drugs In 10 Years, Chabner Tells Group February 3, 1995
TCL Archive Congress Agrees On $1.989 Bil. FY92 NCI Budget, But Most Of Increase Not Available Till 1993 November 8, 1991